Necroptosis related proteins RIPK1, RIPK3 and MLKL were highly expressed in hepatocellular carcinoma cells and tumor tissues with Sorafenib treatment, which means that Sorafenib activated the necroptosis pathway in vitro and in vivo. Here, RIPK1 is linked to neoplasm.